[CAS NO. 1262417-51-5]  NMS-P118

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1262417-51-5]

Catalog
HY-18954
Brand
MCE
CAS
1262417-51-5

DESCRIPTION [1262417-51-5]

Overview

MDL-
Molecular Weight395.42
Molecular FormulaC20H24F3N3O2
SMILESFC(CC1)(F)CCC1N(CC2)CCC2N(C3=O)CC4=C3C(C(N)=O)=CC(F)=C4

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE


Summary

NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy.


IC50 & Target

PARP-1

9 nM (Kd)

PARP-2

1390 nM (Kd)


In Vitro

NMS-P118 is found to be less myelotoxic in vitro than olaparib (now marketed as Lynparza), a dual PARP-1/-2 inhibitor. NMS-P118 proves to be metabolically stable, it modestly inhibites two cytochrome P450 family members (CYP-2B6 IC 50 : 8.15 μM; CYP-2D6 IC 50 : 9.51 μM) out of eight isoforms tested. Its ability in hampering the proliferation of bone marrow cells is from 5 to > 60 times lower then olaparib according to the species [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

NMS-P118 is a potent (K D =0.009 μM) PARP-1 inhibitor, showing 150-fold selectivity over PARP-2 (K D =1.39 μM). NMS-P118 possesses excellent pharmacokinetic profile and nearly complete oral bioavailability both in mice and rats. It proved to be highly efficacious in vivo both as single agent in MDA-MB-436 human breast cancer tumors and in combination with temozolomide in CAPAN-1 human pancreatic tumors growing as xenografts in the mouse. The compound is well tolerated at highly efficacious doses and is endowed with an excellent ADME profile [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 16 mg/mL ( 40.46 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.5290 mL 12.6448 mL 25.2896 mL
5 mM 0.5058 mL 2.5290 mL 5.0579 mL
10 mM 0.2529 mL 1.2645 mL 2.5290 mL
* Please refer to the solubility information to select the appropriate solvent.